These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32964223)

  • 1. Major Adverse Cardiovascular Events During Invasive Pneumococcal Disease Are Serotype Dependent.
    Africano HF; Serrano-Mayorga CC; Ramirez-Valbuena PC; Bustos IG; Bastidas A; Vargas HA; Gómez S; Rodriguez A; Orihuela CJ; Reyes LF
    Clin Infect Dis; 2021 Jun; 72(11):e711-e719. PubMed ID: 32964223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pneumococcal disease burden in hospitalized adults in Bogota, Colombia.
    Narváez PO; Gomez-Duque S; Alarcon JE; Ramirez-Valbuena PC; Serrano-Mayorga CC; Lozada-Arcinegas J; Bastidas A; Gómez S; Vargas H; Feldman C; Reyes LF
    BMC Infect Dis; 2021 Oct; 21(1):1059. PubMed ID: 34641809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Desmet S; Wouters I; Heirstraeten LV; Beutels P; Van Damme P; Malhotra-Kumar S; Maes P; Verhaegen J; Peetermans WE; Lagrou K; Theeten H
    Vaccine; 2021 Jan; 39(2):372-379. PubMed ID: 33308889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Amin-Chowdhury Z; Groves N; Sheppard CL; Litt D; Fry NK; Andrews N; Ladhani SN
    Vaccine; 2021 Apr; 39(14):1997-2004. PubMed ID: 33715901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain.
    González-Díaz A; Càmara J; Ercibengoa M; Cercenado E; Larrosa N; Quesada MD; Fontanals D; Cubero M; Marimón JM; Yuste J; Ardanuy C
    Clin Microbiol Infect; 2020 Jun; 26(6):753-759. PubMed ID: 31756452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.
    Nakano S; Fujisawa T; Ito Y; Chang B; Suga S; Noguchi T; Yamamoto M; Matsumura Y; Nagao M; Takakura S; Ohnishi M; Ihara T; Ichiyama S
    Vaccine; 2016 Jan; 34(1):67-76. PubMed ID: 26602268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Invasive Pneumococcal Disease Caused by Emerging Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in England: A Prospective Observational Cohort Study, 2014-2018.
    Amin-Chowdhury Z; Collins S; Sheppard C; Litt D; Fry NK; Andrews N; Ladhani SN
    Clin Infect Dis; 2020 Nov; 71(8):e235-e243. PubMed ID: 31955196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Ambrose A; Hatchette TF; Lang ALS; Gillis HD; Martin I; Demczuk W; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy AE; McGeer A; Semret M; Trottier S; Valiquette L; Webster D; McNeil SA
    Vaccine; 2019 Aug; 37(36):5466-5473. PubMed ID: 31345638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of invasive pneumococcal disease (IPD) over a 10-year period in Bogotá, Colombia.
    Severiche-Bueno DF; Severiche-Bueno DF; Bastidas A; Caceres EL; Silva E; Lozada J; Gomez S; Vargas H; Viasus D; Reyes LF
    Int J Infect Dis; 2021 Apr; 105():32-39. PubMed ID: 33582374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden.
    Bergman K; Härnqvist T; Backhaus E; Trollfors B; Dahl MS; Kolberg H; Ockborn G; Andersson R; Karlsson J; Mellgren Å; Skovbjerg S
    BMC Infect Dis; 2021 Aug; 21(1):756. PubMed ID: 34348674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia.
    Benavides JA; Ovalle OO; Salvador GR; Gray S; Isaacman D; Rodgers GL
    Vaccine; 2012 Aug; 30(40):5886-92. PubMed ID: 22484295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae associated with invasive pneumococcal disease among adults in Japan.
    Yanagihara K; Kosai K; Mikamo H; Mukae H; Takesue Y; Abe M; Taniguchi K; Petigara T; Kaku M
    Int J Infect Dis; 2021 Jan; 102():260-268. PubMed ID: 33065297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].
    Kara SS; Polat M; Tapisiz A; Nar Otgun S; Tezer H
    Mikrobiyol Bul; 2014 Apr; 48(2):346-50. PubMed ID: 24819273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 32-Year Study of the Effect of Pneumococcal Vaccines on Invasive Streptococcus pneumoniae Disease.
    Stanek RJ; Norton NB; Mufson MA
    Am J Med Sci; 2016 Dec; 352(6):563-573. PubMed ID: 27916211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
    Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
    J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study.
    LeBlanc JJ; ElSherif M; Ye L; MacKinnon-Cameron D; Li L; Ambrose A; Hatchette TF; Lang AL; Gillis H; Martin I; Andrew MK; Boivin G; Bowie W; Green K; Johnstone J; Loeb M; McCarthy A; McGeer A; Moraca S; Semret M; Stiver G; Trottier S; Valiquette L; Webster D; McNeil SA;
    Vaccine; 2017 Jun; 35(29):3647-3654. PubMed ID: 28554501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa.
    Tempia S; Wolter N; Cohen C; Walaza S; von Mollendorf C; Cohen AL; Moyes J; de Gouveia L; Nzenze S; Treurnicht F; Venter M; Groome MJ; Madhi SA; von Gottberg A
    BMC Infect Dis; 2015 Oct; 15():450. PubMed ID: 26496761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
    Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
    Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.